Tomoya Kato
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Tomoya Kato has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Haruo Ohtani
Departments of Pathology
1 shared publicationHisao Kawamura
Department of Pathology, Tsukuba University Hospital, Tsukuba and
1 shared publicationNoriko Kimura
Department of Pathology, Tohoku Rosai Hospital, Sendai, Japan
1 shared publicationShinji Tomida
Gastroenterology, Mito Medical Center, National Hospital Organization, Ibaraki
1 shared publicationTakashi Yamaguchi
Gastroenterology, Mito Medical Center, National Hospital Organization, Ibaraki
1 shared publicationToru Terashima
Surgery, and
1 shared publication
Latest Publications
- 5 July 2005
- Published by Wiley in Pathology International
- Vol. 55 (8) , 524-529
Cytokeratin 20‐positive large cell neuroendocrine carcinoma of the colon
Herein is presented a case of cytokeratin (CK) 20‐positive large cell neuroendocrine carcinoma of the colon, in which the tumor was clinically at stage IV and located in the ascending colon. Pathological examination of the resected tumor revealed nested and solid proliferation of large undifferentiated cells with vesicular nucleus and prominent nucleoli. No areas showed differentiation toward adenocarcinoma or squamous cell carcinoma. Tumor cells were immunohistochemically positive for chromogranin A, synaptophysin, CD 56 (focal), and bore electron‐dense granules. With these features, the tumor was diagnosed as a large cell neuroendocrine carcinoma of the colon. Liver metastasis and local recurrence progressed, and the patient died of the primary disease 7 months after operation. The autopsy confirmed this diagnosis without detectable tumors in the lungs. Interestingly, more than half of the tumor cells were positive for CK 20, while CK 7 was not expressed. Most neuroendocrine carcinomas do not express CK 20, with the exception of Merkel cell carcinomas, and most colorectal adenocarcinomas express CK 20. To the best of the authors’ knowledge, the present case is the first CK 20‐positive, CK 7‐negative colorectal neuroendocrine carcinoma to be described, suggesting a link between colorectal neuroendocrine carcinoma and conventional adenocarcinoma.
- 5 July 2005
- Published by Wiley in Pathology International
- Vol. 55 (8) , 524-529
Cytokeratin 20‐positive large cell neuroendocrine carcinoma of the colon
Herein is presented a case of cytokeratin (CK) 20‐positive large cell neuroendocrine carcinoma of the colon, in which the tumor was clinically at stage IV and located in the ascending colon. Pathological examination of the resected tumor revealed nested and solid proliferation of large undifferentiated cells with vesicular nucleus and prominent nucleoli. No areas showed differentiation toward adenocarcinoma or squamous cell carcinoma. Tumor cells were immunohistochemically positive for chromogranin A, synaptophysin, CD 56 (focal), and bore electron‐dense granules. With these features, the tumor was diagnosed as a large cell neuroendocrine carcinoma of the colon. Liver metastasis and local recurrence progressed, and the patient died of the primary disease 7 months after operation. The autopsy confirmed this diagnosis without detectable tumors in the lungs. Interestingly, more than half of the tumor cells were positive for CK 20, while CK 7 was not expressed. Most neuroendocrine carcinomas do not express CK 20, with the exception of Merkel cell carcinomas, and most colorectal adenocarcinomas express CK 20. To the best of the authors’ knowledge, the present case is the first CK 20‐positive, CK 7‐negative colorectal neuroendocrine carcinoma to be described, suggesting a link between colorectal neuroendocrine carcinoma and conventional adenocarcinoma.